课题基金 / 基金详情

Modulating endocannabinoid transmission as a novel treatment strategy for nicotine addiction

Modulating endocannabinoid transmission as a novel treatment strategy for nicotine addiction
调节内源性大麻素传输作为尼古丁成瘾的新型治疗策略
批准号：
253646
负责人：
Le Foll Bernard
金额：
$27.1万
依托单位：
Centre for Addiction and Mental Health (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2015-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=253646&lang=en
关键词：
Behaviour Craving Endocannabinoid Nicotine Reinstatement

项目摘要

项目成果

Le Foll Bernard的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leading addiction researchers from Canada and the United States are embarking on a multi-year, collaborative project to develop a new therapy for nicotine addiction. The research team includes six scientists led by Dr. Bernard Le Foll, Clinician-Scientist
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Clinical Study: Psilocybin Assisted Psychotherapy as a Novel Treatment for Comorbid Major Depressive Disorder (MDD) and Alcohol Use Disorder (AUD).
The collateral effects of COVID-19 public health policies: Perspectives of people who use opioids and those closest to them using a patient-oriented research approach
Cytisine: testing its potential as a therapeutic strategy for smoking cessation in subjects with concurrent alcohol use disorder
Using ECHO to Address the Needs of Francophone Addiction Service Providers in Ontario
海外基金